Sunday, May 30, 2021

People Want an Alzheimer’s Drug. Aducanumab Isn’t the One.

An F.D.A. sign-off for aducanumab would make finding a good treatment harder.

from NYT > Top Stories https://ift.tt/34psXgz
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

‘We Are Coming From Hell’: A Ukrainian City’s Evacuees Tell Survival Stories

Safely out of Oleshky after enduring years in the combat zone and a harrowing 24-hour journey, weary civilians reunited with family and frie...